Abiologics lures J&J exec to become its CSO

Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer.

The company is reimagining biologics with the creation of a new class of supranatural and programmable medicines, called Synteins, and Dr Magnone brings two decades of experience in all stages of drug development across a wide range of therapeutic areas, said Abiologics.

“Maria-Chiara has the skills, experience and drive to match Abiologics’ ambitious vision to transcend the limits of biology and offer a new class of medicines with significant advantages compared to today’s biologics,” said Avak Kahvejian, co-founder and chief executive of Abiologics and general partner at Flagship Pioneering, adding: “I’m thrilled to welcome her to the team at this critical inflection point for the company as we leverage our platform to create a strong pipeline of supranatural biologics.”